BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2020
View Archived Issues
CAR-T therapy as powerful salvage approach in patients with R/R AL with TP53 alterations
Read More
PPARgamma controls antifibrotic network
Read More
Viral infection may be second hit for familial ALS
Read More
ZBP1 as a new therapeutic target in multiple myeloma
Read More
JNJ-7706621 reverses resistance to CD37-targeted radioimmunotherapy in DLBCL
Read More
Celgene presents first-in-human data for CC-90009
Read More
Cadila Healthcare divulges new antimycobacterial compounds
Read More
Chiesi Farmaceutici identifies ROCK1 and ROCK2 inhibitors
Read More
BioTheryX presents new compounds for cancer
Read More
Chemrar Research & Development Institute discloses dopamine D2 and D3 receptor agonists
Read More
New muscarinic M1 receptor antagonists presented by Pipeline Therapeutics
Read More
Durect discontinues development of DUR-928 for psoriasis
Read More
Opiant signs letter of intent with NCATS to collaborate on OPNT-004 development
Read More
Novel copy number genetic variants identified in Diamond Blackfan anemia
Read More
Orphazyme reports new data and analysis supporting arimoclomol in NPC
Read More
Phase III GRAVITAS-301 study of itacitinib in treatment-naive GvHD misses primary endpoint
Read More
Civi Biopharma studies PCSK9 inhibitor CIVI-007 in phase IIa study
Read More
Novan reports topline efficacy data from phase III B-SIMPLE program of SB-206 for molluscum
Read More
Glutamine transporter variant identified as new cancer target
Read More
Taiwan FDA approves Lumosa's IND for LT-5001 for uremic pruritus
Read More
Sol-Gel initiates phase I study of SGT-210 in punctate palmoplantar keratoderma
Read More